バイオマニュファクチャリング用重要タンパク質市場：グループ、機能、適応症別-2023～2030年の世界予測

バイオマニュファクチャリング用重要タンパク質市場は、予測期間中にCAGR 8.84%で、2022年の483億3,000万米ドルから2030年には948億1,000万米ドルに達すると予測されます。

バイオマニュファクチャリング用重要タンパク質の世界市場

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはバイオマニュファクチャリング用重要タンパク質市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。洞察により、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.バイオマニュファクチャリング用重要タンパク質市場の市場規模および予測は？

2.バイオマニュファクチャリング用重要タンパク質市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.バイオマニュファクチャリング用重要タンパク質市場における競争戦略枠組みとは？

4.バイオマニュファクチャリング用重要タンパク質市場の最新技術動向と規制の枠組みは？

5.バイオマニュファクチャリング用重要タンパク質市場における主要ベンダーの市場シェアは？

6.バイオマニュファクチャリング用重要タンパク質市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 治療効果を高めたバイオ医薬品への需要の増加
    • 複雑なバイオ医薬品を生産するための新しい細胞培養プラットフォームの迅速な導入
    • 個別化医療への関心の高まりにより、カスタマイズ型タンパク質治療が必要
  • 抑制要因
    • 最先端のバイオ製造施設を設立するには多額の資本支出が必要
  • 機会
    • 研究開発への投資を促進する政府の支援政策
    • 重要なタンパク質の技術革新に向けた学界と産業界の継続的なコラボレーション
  • 課題
    • 生産プロセスのスケールアップに伴う複雑さ
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 バイオマニュファクチャリング用重要タンパク質市場：グループ別

• イントロダクション
• サイトカイン
  • ケモカイン
  • コロニー刺激因子
  • インターフェロン
  • インターロイキン
  • 腫瘍壊死因子
• 酵素と化学物質
  • DNAキャッピング酵素
  • エンドヌクレアーゼ
  • グリコシダーゼ
  • ポリアデニル化酵素
  • プロテアーゼ阻害剤
  • 転写酵素
• 発現システム
  • 細菌性
  • 昆虫
  • 哺乳類細胞
  • 酵母
• メディアとサプリメント
  • アルブミン
  • 上皮成長因子（EGF）
  • 線維芽細胞増殖因子（FGF）
  • インスリン様成長因子（IGF）
  • トランスフェリン
  • 血管内皮増殖因子（VEGF）
• プロテインA樹脂
• 品質管理試薬
• ベクターとトランスフェクション試薬

第7章 バイオマニュファクチャリング用重要タンパク質市場：機能別

• イントロダクション
• 診断
• 創薬と開発
  • 生物製剤
  • 細胞および遺伝子治療
  • ワクチン

第8章 バイオマニュファクチャリング用重要タンパク質市場：適応症別

• イントロダクション
• 自己免疫疾患
• 感染症
• 腫瘍学
• 希少遺伝性疾患

第9章 南北アメリカのバイオマニュファクチャリング用重要タンパク質市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のバイオマニュファクチャリング用重要タンパク質市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオマニュファクチャリング用重要タンパク質市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収
  • 新製品発売と機能強化

第13章 競合ポートフォリオ

• 主要な企業プロファイル
  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biologics International Corporation
  • BPS Bioscience, Inc.
  • Bristol-Myers Squibb Company
  • Creative BioMart Inc.
  • Croyez Bioscience Co., Ltd.
  • Eli Lilly and Company
  • Enzo Life Sciences, Inc.
  • GenScript Biotech Corporation
  • Johnson & Johnson Services, Inc.
  • Laurus Bio Private Limited
  • LenioBio GmbH
  • Lonza Group AG
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • ProMab Biotechnologies, Inc.
  • Thermo Fisher Scientific Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2022 VS 2030
• FIGURE 3. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. VITAL PROTEINS FOR BIOMANUFACTURING MARKET DYNAMICS
• FIGURE 7. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2022 VS 2030 (%)
• FIGURE 8. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2022 VS 2030 (%)
• FIGURE 10. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 12. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 14. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 16. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. VITAL PROTEINS FOR BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 22. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 6. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 8. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLONY-STIMULATING FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TUMOR NECROSIS FACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 15. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DNA CAPPING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENDONUCLEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYADENYLATION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSCRIPTION ENZYMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 23. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 29. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EPIDERMAL GROWTH FACTOR (EGF), BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBROBLAST GROWTH FACTORS (FGFS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INSULIN-LIKE GROWTH FACTORS (IGFS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A RESINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY QUALITY CONTROL REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VECTORS & TRANSFECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 39. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 42. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 76. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 77. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 80. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 81. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 82. CANADA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 118. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 119. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 120. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 121. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 122. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 123. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 124. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 126. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 127. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 128. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 129. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 130. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 131. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 132. INDIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 188. TAIWAN VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 190. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 196. THAILAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 204. VIETNAM VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 215. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 218. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 219. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 221. DENMARK VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 223. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 226. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 227. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 228. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 229. EGYPT VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 231. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 234. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 235. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 236. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 237. FINLAND VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 239. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 242. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 243. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 244. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 245. FRANCE VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 247. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 250. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 251. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 252. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 253. GERMANY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 258. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 259. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 260. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 261. ISRAEL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 262. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 263. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 264. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 265. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 266. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 267. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 268. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 269. ITALY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 274. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 275. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 276. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 277. NETHERLANDS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 282. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 283. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 284. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
• TABLE 285. NIGERIA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUPS, 2018-2030 (USD MILLION)
• TABLE 287. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, 2018-2030 (USD MILLION)
• TABLE 288. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES & CHEMICALS, 2018-2030 (USD MILLION)
• TABLE 289. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXPRESSION SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 290. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDIA & SUPPLEMENTS, 2018-2030 (USD MILLION)
• TABLE 291. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 292. NORWAY VITAL PROTEINS FOR BIOMANUFACTURING M

The Vital Proteins for Biomanufacturing Market is projected to reach USD 94.81 billion by 2030 from USD 48.13 billion in 2022, at a CAGR of 8.84% during the forecast period.

Global Vital Proteins for Biomanufacturing Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Vital Proteins for Biomanufacturing Market.

Based on Groups, market is studied across Cytokines, Enzymes & Chemicals, Expression Systems, Media & Supplements, Protein A Resins, Quality Control Reagents, and Vectors & Transfection Reagents. The Cytokines is further studied across Chemokines, Colony-stimulating factors, Interferons, Interleukins, and Tumor necrosis factors. The Enzymes & Chemicals is further studied across DNA Capping Enzymes, Endonucleases, Glycosidases, Polyadenylation Enzymes, Protease Inhibitors, and Transcription Enzymes. The Expression Systems is further studied across Bacterial, Insect, Mammalian Cells, and Yeast. The Media & Supplements is further studied across Albumin, Epidermal Growth Factor (EGF), Fibroblast Growth Factors (FGFs), Insulin-like Growth Factors (IGFs), Transferrin, and Vascular Endothelial Growth Factor (VEGF). The Expression Systems is projected to witness significant market share during forecast period.

Based on Function, market is studied across Diagnostics and Drug Discovery & Development. The Drug Discovery & Development is further studied across Biologics, Cell & Gene Therapy, and Vaccines. The Drug Discovery & Development is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Autoimmune Disorders, Infectious Diseases, Oncology, and Rare Genetic Disorders. The Rare Genetic Disorders is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Vital Proteins for Biomanufacturing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Vital Proteins for Biomanufacturing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Vital Proteins for Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer, Inc., Biologics International Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Creative BioMart Inc., Croyez Bioscience Co., Ltd., Eli Lilly and Company, Enzo Life Sciences, Inc., GenScript Biotech Corporation, Johnson & Johnson Services, Inc., Laurus Bio Private Limited, LenioBio GmbH, Lonza Group AG, Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, ProMab Biotechnologies, Inc., and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Vital Proteins for Biomanufacturing Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Vital Proteins for Biomanufacturing Market?

3. What is the competitive strategic window for identifying opportunities in the Vital Proteins for Biomanufacturing Market?

4. What are the latest technology trends and regulatory frameworks in the Vital Proteins for Biomanufacturing Market?

5. What is the market share of the leading vendors in the Vital Proteins for Biomanufacturing Market?

6. Which modes and strategic moves are suitable for entering the Vital Proteins for Biomanufacturing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Vital Proteins for Biomanufacturing Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for biopharmaceuticals with enhanced therapeutic efficacy
    • 5.1.1.2. Rapid adoption of novel cell culture platforms to produce complex biotherapeutics
    • 5.1.1.3. Growing interest in personalized medicine necessitates tailored protein therapeutics
  • 5.1.2. Restraints
    • 5.1.2.1. High capital expenditure requirements for establishing state-of-the-art biomanufacturing facilities
  • 5.1.3. Opportunities
    • 5.1.3.1. Supportive government policies promoting investments in research & development
    • 5.1.3.2. Ongoing collaborations between academia & industry players for technological innovations in vital proteins
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with scaling up production processes
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Vital Proteins for Biomanufacturing Market, by Groups

• 6.1. Introduction
• 6.2. Cytokines
  • 6.3.1. Chemokines
  • 6.3.2. Colony-stimulating factors
  • 6.3.3. Interferons
  • 6.3.4. Interleukins
  • 6.3.5. Tumor necrosis factors
• 6.3. Enzymes & Chemicals
  • 6.4.1. DNA Capping Enzymes
  • 6.4.2. Endonucleases
  • 6.4.3. Glycosidases
  • 6.4.4. Polyadenylation Enzymes
  • 6.4.5. Protease Inhibitors
  • 6.4.6. Transcription Enzymes
• 6.4. Expression Systems
  • 6.5.1. Bacterial
  • 6.5.2. Insect
  • 6.5.3. Mammalian Cells
  • 6.5.4. Yeast
• 6.5. Media & Supplements
  • 6.6.1. Albumin
  • 6.6.2. Epidermal Growth Factor (EGF)
  • 6.6.3. Fibroblast Growth Factors (FGFs)
  • 6.6.4. Insulin-like Growth Factors (IGFs)
  • 6.6.5. Transferrin
  • 6.6.6. Vascular Endothelial Growth Factor (VEGF)
• 6.6. Protein A Resins
• 6.7. Quality Control Reagents
• 6.8. Vectors & Transfection Reagents

7. Vital Proteins for Biomanufacturing Market, by Function

• 7.1. Introduction
• 7.2. Diagnostics
• 7.3. Drug Discovery & Development
  • 7.4.1. Biologics
  • 7.4.2. Cell & Gene Therapy
  • 7.4.3. Vaccines

8. Vital Proteins for Biomanufacturing Market, by Indication

• 8.1. Introduction
• 8.2. Autoimmune Disorders
• 8.3. Infectious Diseases
• 8.4. Oncology
• 8.5. Rare Genetic Disorders

9. Americas Vital Proteins for Biomanufacturing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Vital Proteins for Biomanufacturing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Vital Proteins for Biomanufacturing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. Everest Medicines Ltd. acquires rights to 3C-like protease inhibitors to develop antivirals for COVID-19
  • 12.3.2. New Product Launch & Enhancement
    • 12.3.2.1. New England Biolabs Introduces Faustovirus Capping Enzyme, a Novel Enzymatic mRNA Capping Solution for mRNA Manufacturing

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Abcam PLC
  • 13.1.2. Abnova Corporation
  • 13.1.3. Agilent Technologies, Inc.
  • 13.1.4. Bio-Rad Laboratories, Inc.
  • 13.1.5. BioLegend, Inc. by PerkinElmer, Inc.
  • 13.1.6. Biologics International Corporation
  • 13.1.7. BPS Bioscience, Inc.
  • 13.1.8. Bristol-Myers Squibb Company
  • 13.1.9. Creative BioMart Inc.
  • 13.1.10. Croyez Bioscience Co., Ltd.
  • 13.1.11. Eli Lilly and Company
  • 13.1.12. Enzo Life Sciences, Inc.
  • 13.1.13. GenScript Biotech Corporation
  • 13.1.14. Johnson & Johnson Services, Inc.
  • 13.1.15. Laurus Bio Private Limited
  • 13.1.16. LenioBio GmbH
  • 13.1.17. Lonza Group AG
  • 13.1.18. Merck KGaA
  • 13.1.19. Meridian Bioscience, Inc. by SD Biosensor Inc.
  • 13.1.20. Miltenyi Biotec B.V. & Co. KG
  • 13.1.21. Novartis AG
  • 13.1.22. ProMab Biotechnologies, Inc.
  • 13.1.23. Thermo Fisher Scientific Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing